Randomized study of the safety and pharmacodynamics of inhaled interleukin-13 monoclonal antibody fragment VR942

por Burgess, Gary, Boyce, Malcolm, Jones, Margaret, Larsson, Lars, Main, Mark J., Morgan, Frazer, Phillips, Peter, Scrimgeour, Alison, Strimenopoulou, Foteini, Vajjah, Pavan, Zamacona, Miren, Palframan, Roger
Publicado 2018

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

por Jagannathan, Prasanna, Chew, Kara W., Giganti, Mark J., Hughes, Michael D., Moser, Carlee, Main, Mark J., Monk, Phillip D., Javan, Arzhang Cyrus, Li, Jonathan Z., Fletcher, Courtney V., McCarthy, Caitlyn, Wohl, David A., Daar, Eric S., Eron, Joseph J., Currier, Judith S., Singh, Upinder, Smith, Davey M., Fischer, William
Publicado 2023